News

Bayer, a global leader in radiology and cardiology, has struck a major deal to acquire two investigational molecular imaging agents from clinical-stage…

Prof. Liu Cong from the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences, along with collaborators, has revealed the high-resolution…

There has been an uptick in volume in recent years for cardiac amyloidosis imaging. Securing an early diagnosis of the disease is crucial to initiate drug treatment…

Not intended for UK MediaBayer bolsters development portfolio by acquisition of two investigational imaging agents (AT-01 and AT-05) from Attralus, Inc. to advance…

Bayer, looking to bolster its position in both imaging and cardiac medicine, struck a deal to snap up two experimental imaging agents and thereby enter the…

The number of people diagnosed with transthyretin amyloidosis (ATTR) in the U.S. is climbing, a surge researchers attribute to better medical awareness and more…

Canada: A case reported in the Canadian Medical Association Journal highlights insulin injection amyloidosis as an underrecognized complication of repeated…

An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein transthyretin that cause transthyretin…

HistoryThe subtype of TTR protein mutation, its tissue distribution, and the amount of amyloid deposition largely determine the clinical manifestations of ATTR. The…

An amyloidosis diagnosis brings a rush of questions. Where should I go? Who truly understands this disease? Are there clinical trials for someone like me? For too…